Clinical Trial

Evaluation of Heart Failure Telemonitoring Eligibility Criteria

Study acronym: Weigh-HF
Recruiting
View on ClinicalTrials.gov →
Summary
CARDIAUVERGNE is a heart failure telemonitoring system at Clermont-Ferrand's hospital. The aim of this study is to analyze the prognosis and evolution of patients after exclusion of telemonitoring. The patients were included from 1st January 2023 to 31st December 2024 and the monitoring was terminated for end of eligibility according to the French health authority criteria.
Protocol Amendment History 1 change
critical Recruitment opened 2026-07-31
Trial Details
NCT Number NCT07278583
Lead Sponsor University Hospital, Clermont-Ferrand
Conditions Heart Failure
Enrollment 130 participants
Start Date 2025-12-05
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-30